MRNA therapy hopes to control copper buildup in wilson disease
Disease control
Recruiting now
This early-stage trial tests a new medicine called DSL101 for Wilson disease, a genetic condition that causes copper buildup in the body. The study will give the drug through an IV to 18 adults to check if it is safe and helps control copper levels. The goal is to manage the dise…
Phase: EARLY_PHASE1 • Sponsor: DSciLab Co., Ltd. • Aim: Disease control
Last updated May 05, 2026 11:52 UTC